Effects of Exercise on Dystonia Pathophysiology

Sponsor
University of Florida (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05663840
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
56
1
2
60
0.9

Study Details

Study Description

Brief Summary

The purpose of this research study is to investigate how the brain and motor behavior changes in individuals with dystonia in response to exercise training.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Progressive resistance exercise
  • Behavioral: Standard of care
N/A

Detailed Description

Dystonia is a debilitating movement disorder. It involves involuntary muscle contractions with abnormal and repetitive movements, postures, or both. The current treatments for dystonia comprise of oral medications, botulinum toxin injections, and deep brain stimulation surgery. These treatments, despite optimal management, fail to improve symptoms in more than a third of patients and the improvements are often unpredictable. We will investigate the brain adaptation effects for progressive resistance exercise-focused cervical and shoulder training (PERFECT) in patients with focal cervical dystonia with functional MRI (fMRI) and transcranial magnetic stimulation (TMS) techniques for understanding the pathophysiology of dystonia and treatment related changes. The investigators propose to enroll patients with predominantly focal cervical dystonia and compare PERFECT plus standard-of-care (SOC) therapy (n = 27) with a control group of SOC therapy (n = 27). Participants in the PERFECT + SOC group will perform physical therapist-guided exercises twice a week for 6 months and participants in the SOC group will continue receiving standard pharmacological therapies at stable doses and they will not exercise.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Progressive Resistance Exercise and Dystonia Pathophysiology.
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2027
Anticipated Study Completion Date :
Dec 31, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Progressive resistance exercise (exercise group)

Subjects will receive physical therapy that will predominantly include progressive resistance exercise training program along with continuation of standard of care (exercise group)

Behavioral: Progressive resistance exercise
Patients with predominant symptoms of cervical dystonia will receive exercise training. Patients will receive progressive resistance exercise focused cervical and shoulder training (PERFECT) plus standard-of-care (SOC) therapy. Resistance training will consist of mainly muscle-strengthening exercises for the neck, shoulder and arms and a few upper trunk muscles. Resistance training will be guided by physical therapists at twice a week schedule for 6 months. These participants will also receive SOC therapy.

Active Comparator: Standard of care (non-exercise group).

Subjects will receive continuation of standard of care (non-exercise group).

Behavioral: Standard of care
Subjects will receive SOC therapy only

Outcome Measures

Primary Outcome Measures

  1. Brain effects measured with fMRI [Baseline up to 6 months]

    To measure change in BOLD (fMRI) signals to functional connectivity in active group vs the control group.

  2. Brain effects measured with TMS [Baseline up to 6 months]

    To measure motor cortex excitability and plasticity in TMS findings.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients have predominantly focal cervical dystonia and whose diagnosis will be confirmed by a movement disorders specialist following criteria recommended by Movement Disorders Society.

  • Moderate disease severity.

  • Are 30 to 85 years old

  • Are able to tolerate exercise sessions.

  • Reporting suboptimal clinical benefits despite receiving maximally tolerated doses of BoNT injections for the neck muscles and/or oral pharmacological therapy.

Exclusion Criteria:
  • Participating in an alternate structured exercise program, receiving regular physical or occupational therapy

  • Have significant pain, spondylosis or active arthritis

  • Fail the Physical Activity Readiness Questionnaire

  • Have significant cognitive impairment

  • Have implanted electrical device (eg, cardiac pacemaker or a DBS or a neurostimulator or metallic clip in their body, as necessitated by the risks of MRI or TMS

  • Active seizure disorder; not be eligible for TMS and claustrophobic for MRI portion. As necessitated by the risks of MRI or TMS, patients who have any type of implanted electrical device (such as a cardiac pacemaker or a neurostimulator), or a certain type of metallic clip in their body (i.e., an aneurysm clip in the brain), active seizure disorder are not eligible for participation in the MRI or TMS portion of the study.

  • Pregnancy tests will be carried out for each female subject of child bearing potential prior to the participation in the study and prior to each follow up visit (as indicated).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Florida Gainesville Florida United States 32611

Sponsors and Collaborators

  • University of Florida
  • National Institute of Neurological Disorders and Stroke (NINDS)

Investigators

  • Principal Investigator: Aparna Wagle Shukla, MD, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT05663840
Other Study ID Numbers:
  • IRB202200490
  • 1R01NS122943
First Posted:
Dec 23, 2022
Last Update Posted:
Dec 23, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2022